Bleomycin-induced scleroderma

Related Experiment Video

Updated: Aug 12, 2026

Induction of Mouse Lung Injury by Endotracheal Injection of Bleomycin
06:52

Induction of Mouse Lung Injury by Endotracheal Injection of Bleomycin

Published on: April 30, 2019

Shefali K Sharma1, R Handa, Rita Sood

  • 1Department of Medicine, All India Institute of Medical Sciences, New Delhi.

The Journal of the Association of Physicians of India
|January 7, 2005
PubMed

Abstract:

Systemic sclerosis is a connective tissue disease, which can be triggered by environmental factors. We report one such case of bleomycin-induced scleroderma.

More Related Videos

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis
06:03

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis

Published on: May 9, 2025

A Refined Aerosol-Based Intratracheal Bleomycin Delivery Method for Reproducible and Minimally Invasive Mouse Models of Pulmonary Fibrosis
05:45

A Refined Aerosol-Based Intratracheal Bleomycin Delivery Method for Reproducible and Minimally Invasive Mouse Models of Pulmonary Fibrosis

Published on: January 16, 2026

Related Experiment Videos

Last Updated: Aug 12, 2026

Induction of Mouse Lung Injury by Endotracheal Injection of Bleomycin
06:52

Induction of Mouse Lung Injury by Endotracheal Injection of Bleomycin

Published on: April 30, 2019

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis06:03

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis

Published on: May 9, 2025

A Refined Aerosol-Based Intratracheal Bleomycin Delivery Method for Reproducible and Minimally Invasive Mouse Models of Pulmonary Fibrosis05:45

A Refined Aerosol-Based Intratracheal Bleomycin Delivery Method for Reproducible and Minimally Invasive Mouse Models of Pulmonary Fibrosis

Published on: January 16, 2026

Related Concept Videos

Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...

Articles linked to this work by shared authors, journal, and citation graph.

Maternal and Child Health Status among Women Attending an Antenatal Clinic in a Tertiary Care Hospital of Bangladesh.

Mymensingh medical journal : MMJ·2026

Radiologic Phenotyping in Patients with SOX10 Pathogenic Variants: Insights into Neck, Brain, and Temporal Bone Abnormalities.

AJNR. American journal of neuroradiology·2026

Outcome of hemiarthroplasty to total hip arthroplasty conversion: a systematic review.

Musculoskeletal surgery·2025

Projections between the globus pallidus externa and cortex span motor and non-motor regions.

bioRxiv : the preprint server for biology·2024

Medium dynamic field range linear bipolar spin valve sensor through soft pinning the sensing layer.

Journal of physics. Condensed matter : an Institute of Physics journal·2024

Vertical heterostructure of graphite-MoS2 for gas sensing.

Nanoscale horizons·2024

Risk Factors and Emerging Therapies for Immune Checkpoint Inhibitor-related Myocarditis: A Narrative Review.

The Journal of the Association of Physicians of India·2026

Updates in Rhinitis: A Comprehensive Review of Recent Advances.

The Journal of the Association of Physicians of India·2026

Understanding Obesity through a Public Health Lens.

The Journal of the Association of Physicians of India·2026

Real-world Challenges and Predictors of Success in Glucagon-like Peptide-1 Receptor Agonist Therapy.

The Journal of the Association of Physicians of India·2026

Optimizing Catheter Removal in Amebic Liver Abscess: A Simplified Protocol for Faster Recovery.

The Journal of the Association of Physicians of India·2026

Candidemia in ICU and Non-ICU Settings: Species Distribution and Antifungal Resistance Patterns from a Tertiary Care Center in India with Reference to ICMR AMR 2024.

The Journal of the Association of Physicians of India·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us